|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||||
| Cash and due from banks: | ||||||||||||||||||||
| Noninterest bearing deposits and cash | ||||||||||||||||||||
| Interest bearing deposits | ||||||||||||||||||||
| Restricted cash | ||||||||||||||||||||
| Total cash, cash equivalents and restricted cash | ||||||||||||||||||||
| Available-for-sale securities, at fair value | ||||||||||||||||||||
| Other investments, at cost | ||||||||||||||||||||
| Total investment securities | ||||||||||||||||||||
| Federal Reserve Bank (FRB) stock, at cost | ||||||||||||||||||||
| Federal Home Loan Bank (FHLB) stock, at cost | ||||||||||||||||||||
| Loans receivable (net of allowance for credit losses: 2026: $(8,469) and 2025: $(6,839)) | ||||||||||||||||||||
| Loans held for sale | ||||||||||||||||||||
| Accrued interest and dividends receivable | ||||||||||||||||||||
| Premises and equipment, net | ||||||||||||||||||||
| Other real estate owned | ||||||||||||||||||||
| Deferred tax asset | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Core deposit intangible, net | ||||||||||||||||||||
| Other assets | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| Liabilities | ||||||||||||||||||||
| Deposits: | ||||||||||||||||||||
| Noninterest bearing deposits | ||||||||||||||||||||
| Interest bearing deposits | ||||||||||||||||||||
| Total deposits | ||||||||||||||||||||
| FHLB, FRB and correspondent bank borrowings | ||||||||||||||||||||
| Senior notes, net | ||||||||||||||||||||
| Subordinated debt, net | ||||||||||||||||||||
| Junior subordinated debt | ||||||||||||||||||||
| Note payable | ||||||||||||||||||||
| Advances from borrowers for taxes and insurance | ||||||||||||||||||||
| Accrued expenses and other liabilities | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Shareholders' equity | ||||||||||||||||||||
| Preferred stock, no par value; 1,000,000 shares authorized; As of June 30, 2025: 90,832 shares issued and outstanding; As of December 31, 2024: no shares issued and outstanding. | ||||||||||||||||||||
| Common stock | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Accumulated deficit | ||||||||||||||||||||
| Treasury stock, at cost; 73,741 shares at June 30, 2026 and December 31, 2025 | ||||||||||||||||||||
| Accumulated other comprehensive loss | ||||||||||||||||||||
| Total shareholders' equity | ||||||||||||||||||||
| Total liabilities and shareholders' equity | ||||||||||||||||||||
Loading...
